BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34895326)

  • 1. A uracil auxotroph Toxoplasma gondii exerting immunomodulation to inhibit breast cancer growth and metastasis.
    Xu LQ; Yao LJ; Jiang D; Zhou LJ; Chen M; Liao WZ; Zou WH; Peng HJ
    Parasit Vectors; 2021 Dec; 14(1):601. PubMed ID: 34895326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii.
    Fox BA; Bzik DJ
    Infect Immun; 2010 Sep; 78(9):3744-52. PubMed ID: 20605980
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Chen M; Yang P; Xin Z; Chen J; Zou W; Zhou L; Yang L; Peng J; Peng H
    Front Immunol; 2023; 14():1173379. PubMed ID: 37426671
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.
    Fox BA; Sanders KL; Chen S; Bzik DJ
    Trends Parasitol; 2013 Sep; 29(9):431-7. PubMed ID: 23928100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential cure for tumor-associated immunosuppression by Toxoplasma gondii.
    Lotfalizadeh N; Sadr S; Morovati S; Lotfalizadeh M; Hajjafari A; Borji H
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1963. PubMed ID: 38109851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infection.
    Fox BA; Bzik DJ
    Infect Immun; 2015 May; 83(5):2148-55. PubMed ID: 25776745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
    Zhao Y; Huang B; Huang S; Zheng H; Li YQ; Lun ZR; Shen J; Wang Y; Kasper LH; Lu F
    Parasitol Res; 2013 Sep; 112(9):3151-60. PubMed ID: 23783399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.
    Meng M; He S; Zhao G; Bai Y; Zhou H; Cong H; Lu G; Zhao Q; Zhu XQ
    Parasit Vectors; 2012 Nov; 5():273. PubMed ID: 23181694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication.
    Gigley JP; Fox BA; Bzik DJ
    J Immunol; 2009 Jan; 182(2):1069-78. PubMed ID: 19124750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence-related gene wx2 of Toxoplasma gondii regulated host immune response via classic pyroptosis pathway.
    Ma Z; Li Z; Jiang R; Li X; Yan K; Zhang N; Lu B; Huang Y; Dibo N; Wu X
    Parasit Vectors; 2022 Dec; 15(1):454. PubMed ID: 36471417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and gamma-interferon.
    Nguyen TD; Bigaignon G; Markine-Goriaynoff D; Heremans H; Nguyen TN; Warnier G; Delmee M; Warny M; Wolf SF; Uyttenhove C; Van Snick J; Coutelier JP
    J Med Microbiol; 2003 Oct; 52(Pt 10):869-876. PubMed ID: 12972580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.
    Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA
    Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effect of TNF-alpha and IFN-gamma in retinal cell infection with Toxoplasma gondii.
    Delair E; Creuzet C; Dupouy-Camet J; Roisin MP
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1754-60. PubMed ID: 19321794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.
    Zhang NZ; Xu Y; Wang M; Chen J; Huang SY; Gao Q; Zhu XQ
    BMC Infect Dis; 2016 Apr; 16():168. PubMed ID: 27090890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.
    Baird JR; Fox BA; Sanders KL; Lizotte PH; Cubillos-Ruiz JR; Scarlett UK; Rutkowski MR; Conejo-Garcia JR; Fiering S; Bzik DJ
    Cancer Res; 2013 Jul; 73(13):3842-51. PubMed ID: 23704211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity.
    Fox BA; Sanders KL; Rommereim LM; Guevara RB; Bzik DJ
    PLoS Genet; 2016 Jul; 12(7):e1006189. PubMed ID: 27447180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of deletion of gra17 and gra23 genes on the growth, virulence, and immunogenicity of type II Toxoplasma gondii.
    Li TT; Wang JL; Liang QL; Sun LX; Zhang HS; Zhang ZW; Zhu XQ; Elsheikha HM
    Parasitol Res; 2020 Sep; 119(9):2907-2916. PubMed ID: 32686022
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chen J; Liao W; Peng H
    Front Cell Infect Microbiol; 2022; 12():959300. PubMed ID: 36118042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma.
    Luo KW; Yue GG; Ko CH; Lee JK; Gao S; Li LF; Li G; Fung KP; Leung PC; Lau CB
    Phytomedicine; 2014; 21(8-9):1078-87. PubMed ID: 24856767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization With a Live-Attenuated RH:Δ
    Yang WB; Wang JL; Gui Q; Zou Y; Chen K; Liu Q; Liang QL; Zhu XQ; Zhou DH
    Front Microbiol; 2019; 10():1875. PubMed ID: 31456786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.